相关实验视频
Updated: Jun 25, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
维尼托克拉克斯作为免疫代谢调节剂,增强了针对白血病的采用NK细胞免疫疗法
Yan Wang1, Beibei Huang2, Tingting Liang1
1Department of Hematology, The First Affiliated Hospital of USTC, Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China; Institute of Immunology, The CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
作为BCL-2抑制剂的Venetoclax直接激活自然杀手 (NK) 细胞,增强它们对急性髓性白血病 (AML) 的杀癌能力. 这种药物增强NK细胞功能,并显示出改善免疫疗法策略的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自然杀手 (NK) 细胞免疫疗法显示出癌症治疗的潜力,但面临着局限性.
- 开发新的策略来提高NK细胞的疗效对于改善患者的治疗结果至关重要.
研究的目的:
- 研究venetoclax对NK细胞激活和细胞毒性的直接影响.
- 探索维尼托克拉克斯诱导的NK细胞增强对急性髓性白血病 (AML) 的潜在机制.
主要方法:
- 使用了批量和单细胞RNA测序,狂热度测量和功能测试.
- 评估NK细胞细胞毒性,质颗粒极化和线粒体功能.
- 研究了NF-κB通路在venetoclax介导作用中的作用.
主要成果:
- 维内托克拉克斯直接激活NK细胞,增强它们在体外和体内对AML细胞的细胞毒性.
- 维尼托克拉克斯增加NK细胞对AML细胞的热情,并在免疫突触形成过程中促进了Lytic颗粒的两极化.
- 确定了对venetoclax敏感的特定NK细胞亚群 (CD161低CD218b+),并发现venetoclax通过NF-κB通路增强线粒体呼吸和ATP合成.
结论:
- 维内托克拉克斯作为免疫代谢调节剂,增强NK细胞功能,独立于BCL-2抑制.
- 威尼托克拉克斯 (Venetoclax) 是一种有前途的治疗策略,用于增强NK细胞的癌症免疫疗法,特别是针对AML.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

